Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > US Trial

<< Previous

Bullboard Posts

Next >>

Post by okgonowon May 15, 2024 9:08am

157 Views

Post# 36040750

US Trial

just that one trial at the U in california is $500 k per year high margin revenue and MPL is the only FDA/DEA lic. supplier now that they are close to re sced. emagine how many more of those trial will get going and MPL will be the place to get their supply

great opertunity!!

also the coment of the Multiple new International parters that have just been signed up with more to come expecting revenenues ton be geerated later this Q....very positive

<< Previous

Bullboard Posts

Next >>

Quantum eMotion leaps by 20 per cent after Becton Dickinson deal